Direct Offering

4 stories about Direct Offering
נאסד"ק וול סטריט

Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering

Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
נאסדק נאסד"ק ניו יורק בורסה בועה

Biotech Company Compugen Down on Nasdaq Following $21 Million Direct Offering

17.06.18|Dror Reich
The Israel-based cancer immunotherapy company intends to use the proceedings for product development
נאסדק נאסד"ק ניו יורק בורסה בועה

OrbiMed Invests $16 Million in Derma Company Foamix

17.04.18|Lilach Baumer
Foamix is a clinical-stage company developing specialty foam-based treatments for skin conditions such as acne
נאסד"ק וול סטריט

Liver Treatment Company Galmed is Raising $6 Million in Direct Offering

04.04.18|Lilach Baumer
The company’s stock fell by 37% on Nasdaq since the beginning of the year, and by 66% since its Nasdaq listing in 2014